Trial Profile
Pregabalin open-label, follow-on safety trial in patients with refractory partial epilepsy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Jul 2007
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions
- Sponsors Pfizer
- 27 Nov 2005 New trial record.